首页 > 最新文献

Medicamentos de actualidad. Drugs of today最新文献

英文 中文
New product intros [desidustat, difamilast, mitapivat sulfate (first-in-class), mosunetuzumab (first-in-class), olipudase alfa] 新产品引入[地西司他、迪米司特、硫酸米他伐特(同类首创)、莫舒尼妥珠单抗(同类首创)、脂酶α]
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.8.3459805
A. Babu
{"title":"New product intros [desidustat, difamilast, mitapivat sulfate (first-in-class), mosunetuzumab (first-in-class), olipudase alfa]","authors":"A. Babu","doi":"10.1358/dot.2022.58.8.3459805","DOIUrl":"https://doi.org/10.1358/dot.2022.58.8.3459805","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros [deucravacitinib (first-in-class); eflapegrastim; ensitrelvir; monovalent, recombinant-protein next-generation COVID-19 vaccine, adjuvanted using GSK's pandemic adjuvant; tozinameran/famtozinameran] 新产品介绍[deucravacitinib (first-in-class);eflapegrastim;ensitrelvir;单价重组蛋白新一代COVID-19疫苗，佐剂为GSK的大流行佐剂;tozinameran / famtozinameran]
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.12.3531367
{"title":"New product intros [deucravacitinib (first-in-class); eflapegrastim; ensitrelvir; monovalent, recombinant-protein next-generation COVID-19 vaccine, adjuvanted using GSK's pandemic adjuvant; tozinameran/famtozinameran]","authors":"","doi":"10.1358/dot.2022.58.12.3531367","DOIUrl":"https://doi.org/10.1358/dot.2022.58.12.3531367","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat, pneumococcal 23-valent polysaccharide vaccine, sirolimus protein-bound particles for injectable suspension, somatrogon) 新产品介绍(小鼠胶原蛋白中异体培养的角质形成细胞和真皮成纤维细胞，肺炎球菌23价多糖疫苗，注射用西罗莫司蛋白结合颗粒，生长激素)
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.4.3428872
{"title":"New product intros (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen-dsat, pneumococcal 23-valent polysaccharide vaccine, sirolimus protein-bound particles for injectable suspension, somatrogon)","authors":"","doi":"10.1358/dot.2022.58.4.3428872","DOIUrl":"https://doi.org/10.1358/dot.2022.58.4.3428872","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination)) 新产品介绍(非那雄胺/他达拉非(新组合);sutimlimab;AS03佐剂重组人SARS-CoV-2纳米颗粒疫苗盐酸安非他酮/氢溴酸右美沙芬(新组合)
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.11.3513402
{"title":"New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))","authors":"","doi":"10.1358/dot.2022.58.11.3513402","DOIUrl":"https://doi.org/10.1358/dot.2022.58.11.3513402","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros [abrocitinib, avacopan, finerenone, maribavir, molnupiravir, olverembatinib mesylate, pilocarpine hydrochloride (new indication), pneumococcal 20-valent conjugate vaccine, sacubitril valsartan cocrystal (new indication)] 新产品介绍[阿布替尼、阿伐科泮、芬尼酮、马里巴韦、莫努匹拉韦、甲磺酸奥维巴替尼、盐酸匹洛卡平(新适应症)、肺炎球菌20价结合疫苗、苏比里尔缬沙坦共晶(新适应症)]
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.1.3406261
{"title":"New product intros [abrocitinib, avacopan, finerenone, maribavir, molnupiravir, olverembatinib mesylate, pilocarpine hydrochloride (new indication), pneumococcal 20-valent conjugate vaccine, sacubitril valsartan cocrystal (new indication)]","authors":"","doi":"10.1358/dot.2022.58.1.3406261","DOIUrl":"https://doi.org/10.1358/dot.2022.58.1.3406261","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66458886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros [ansuvimab; benzoyl peroxide/tretinoin (new combination); faricimab; gallium (68Ga) gozetotide, kit for preparation; leuprolide mesylate; lutetium (177Lu) vipivotide tetraxetan; SARS-CoV-2 recombinant spike protein nanoparticle vaccine] 新产品介绍[ansuvimab;过氧化苯甲酰/维甲酸(新组合);faricimab;镓(68Ga) gozetotide，制备试剂盒;leuprolide甲磺酸;镥(177Lu) vipivotide tetraxetan;SARS-CoV-2重组刺突蛋白纳米颗粒疫苗
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.5.3437188
{"title":"New product intros [ansuvimab; benzoyl peroxide/tretinoin (new combination); faricimab; gallium (68Ga) gozetotide, kit for preparation; leuprolide mesylate; lutetium (177Lu) vipivotide tetraxetan; SARS-CoV-2 recombinant spike protein nanoparticle vaccine]","authors":"","doi":"10.1358/dot.2022.58.5.3437188","DOIUrl":"https://doi.org/10.1358/dot.2022.58.5.3437188","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
New product intros [allogeneic processed thymus tissue-agdc, ciltacabtagene autoleucel, clazosentan sodium, daridorexant, gefapixant citrate (first-in-class), mavacamten (first-in-class), nivolumab/relatlimab-rmbw (new combination), relmacabtagene autoleucel] 新产品引进[同种异体胸腺组织-agdc，西他卡塔格尼自甲苯，克唑森坦钠，达瑞多耐药，柠檬酸吉法匹昔(同类首创)，马伐卡坦(同类首创)，尼武单抗/relatlimab-rmbw(新组合)，雷马卡塔格尼自甲苯]
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.6.3443511
{"title":"New product intros [allogeneic processed thymus tissue-agdc, ciltacabtagene autoleucel, clazosentan sodium, daridorexant, gefapixant citrate (first-in-class), mavacamten (first-in-class), nivolumab/relatlimab-rmbw (new combination), relmacabtagene autoleucel]","authors":"","doi":"10.1358/dot.2022.58.6.3443511","DOIUrl":"https://doi.org/10.1358/dot.2022.58.6.3443511","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros (darinaparsin, eladocagene exuparvovec, fexuprazan hydrochloride, nemolizumab (first-in-class), pimitespib, tirzepatide (first-in-class)) 新产品引进(darinparsin、eladocagene exuparvovec、盐酸非特普拉赞、奈莫单抗(同类首创)、吡咪司匹、替西帕肽(同类首创))
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.10.3487255
{"title":"New product intros (darinaparsin, eladocagene exuparvovec, fexuprazan hydrochloride, nemolizumab (first-in-class), pimitespib, tirzepatide (first-in-class))","authors":"","doi":"10.1358/dot.2022.58.10.3487255","DOIUrl":"https://doi.org/10.1358/dot.2022.58.10.3487255","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66458953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros [carotegrast methyl, difelikefalin (first-in-class), fosnetupitant chloride hydrochloride, pacritinib, serplulimab, sugemalimab, tebentafusp (first-in-class), tolvaptan sodium phosphate] 新产品介绍[甲基胡萝卜素、异花铁素(一流)、盐酸氟硝吡坦、帕西替尼、serplulimab、sugemalimab、tebentafusp(一流)、托伐坦磷酸钠]
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.7.3453462
{"title":"New product intros [carotegrast methyl, difelikefalin (first-in-class), fosnetupitant chloride hydrochloride, pacritinib, serplulimab, sugemalimab, tebentafusp (first-in-class), tolvaptan sodium phosphate]","authors":"","doi":"10.1358/dot.2022.58.7.3453462","DOIUrl":"https://doi.org/10.1358/dot.2022.58.7.3453462","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New product intros [amubarvimab/romlusevimab (new combination); cadonilimab (first-in-class); ganaxolone; oteseconazole; sodium phenylbutyrate/ursodoxicoltaurine (new combination); tramadol celecoxib cocrystal (first-in-class)] 新产品介绍[amubarvimab/romlusevimab(新组合);cadonilimab (first-in-class);ganaxolone;oteseconazole;苯丁酸钠/熊多醇牛磺酸(新组合);曲马多塞来昔布共晶(一流)
Medicamentos de actualidad. Drugs of today
Pub Date : 2022-01-01 DOI: 10.1358/dot.2022.58.9.3473075
{"title":"New product intros [amubarvimab/romlusevimab (new combination); cadonilimab (first-in-class); ganaxolone; oteseconazole; sodium phenylbutyrate/ursodoxicoltaurine (new combination); tramadol celecoxib cocrystal (first-in-class)]","authors":"","doi":"10.1358/dot.2022.58.9.3473075","DOIUrl":"https://doi.org/10.1358/dot.2022.58.9.3473075","url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"74 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66459142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Medicamentos de actualidad. Drugs of today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1